Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it mattersMarkus Ketteler, Mary B. Leonard, Geoffrey A. Block et al.|Kidney International|2017Cited by 998
COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaborationLuuk B. Hilbrands, Elena Zakharova, Raphaël Duivenvoorden et al.|Nephrology Dialysis Transplantation|2020Cited by 411
Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease–Mineral and Bone Disorder: Synopsis of the Kidney Disease: Improving Global Outcomes 2017 Clinical Practice Guideline UpdateMarkus Ketteler, Mary B. Leonard, Rukshana Shroff et al.|Annals of Internal Medicine|2018Cited by 316
Prevalence, outcomes, and cost of chronic kidney disease in a contemporary population of 2·4 million patients from 11 countries: The CaReMe CKD studyJohan Sundström, Navdeep Tangri, Johan Bodegård et al.|The Lancet Regional Health - Europe|2022Cited by 315
European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4–G5DPieter Evenepoel, Goce Spasovski, John Cunningham et al.|Nephrology Dialysis Transplantation|2020Cited by 185